Shortening MDR-TB treatment: is treating more patients with fewer drugs better?

Int J Tuberc Lung Dis. 2021 Jun 1;25(6):419-420. doi: 10.5588/ijtld.21.0146.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Pharmaceutical Preparations*
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents
  • Pharmaceutical Preparations